4//SEC Filing
ARCA biopharma, Inc. 4
Accession 0001209191-14-015845
$ORKACIK 0000907654operating
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:29 PM ET
Size
9.6 KB
Accession
0001209191-14-015845
Insider Transaction Report
Form 4
BRISTOW MICHAEL R
DirectorChief Science and Med. Officer
Transactions
- Award
Common Stock
2014-02-27$1.95/sh+56,700$110,565→ 306,478 total - Award
Stock Option (right to buy)
2014-02-27+51,500→ 51,500 totalExercise: $1.95Exp: 2024-02-27→ Common Stock (51,500 underlying)
Holdings
- 139,082(indirect: By Trust)
Common Stock
- 178,215(indirect: By IRA)
Common Stock
Footnotes (3)
- [F1]Represents shares issued as restricted stock units (an "RSU") under the Issuer's 2013 Equity Incentive Plan (the "Plan"). The RSUs vest in four equal annual installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time.
- [F2]Includes 125,000 previously reported shares issued as restricted stock units under the Plan.
- [F3](3) Grant to the Reporting Person of a stock option under the Plan, vesting in 48 equal monthly installments from the date of grant, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan prior to such time. In the event of a change in control of the Issuer, 50% of the unvested options shall become fully and immediately vested upon the closing date of such change in control, provided, however, that on the earlier of (i) the one-year anniversary of the closing date or (ii) involuntary termination, any options that remain unvested on such earlier date shall become fully and immediately vested.
Documents
Issuer
ARCA biopharma, Inc.
CIK 0000907654
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000907654
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:29 PM ET
- Size
- 9.6 KB